Alerts will be sent to your verified email
Verify Email
SANJIVIN
|
Sanjivani Paranteral
|
Gennex Lab
|
Natural Capsules
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Quarterly Sales Volume - Injectables
|
n/a | n/a | n/a |
|
Quarterly Sales Volume - Orals
|
n/a | n/a | n/a |
|
Quarterly Sales Volume - Nutraceuticals
|
n/a | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
-37.68 % | 7.82 % | 9.1 % |
|
5yr average Equity Multiplier
|
-1.69 | 1.53 | 1.91 |
|
5yr Average Asset Turnover Ratio
|
1.39 | 0.75 | 0.61 |
|
5yr Avg Net Profit Margin
|
7.02 % | 7.88 % | 6.68 % |
|
Price to Book
|
7.16 | 1.46 | 1.21 |
|
P/E
|
33.56 | 16.16 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
-55.03 Days | 43.23 Days | 25.72 Days |
|
Inventory Days
|
28.68 Days | 49.12 Days | 27.47 Days |
|
Days Receivable
|
21.4 Days | 50.53 Days | 125.88 Days |
|
Days Payable
|
284.6 Days | 75.36 Days | 118.63 Days |
|
5yr Average Interest Coverage Ratio
|
15.99 | 6.21 | 7.96 |
|
5yr Avg ROCE
|
-87.74 % | 11.17 % | 10.02 % |
|
5yr Avg Operating Profit Margin
|
9.71 % | 10.47 % | 14.83 % |
|
5 yr average Debt to Equity
|
-0.72 | 0.18 | 0.51 |
|
5yr CAGR Net Profit
|
n/a | 43.63 % | -38.15 % |
|
5yr Average Return on Assets
|
11.72 % | 5.16 % | 4.68 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
28.87 % | 19.83 % | 51.26 % |
|
Share Pledged by Promoters
|
0.0 | 21.79 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.52 % | -2.22 % | -5.31 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Sanjivani Paranteral
|
Gennex Lab
|
Natural Capsules
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|